GlassScriptPhysician profile
Roderick Cecil Hunter
NPI 1811128051
$4,131.83
in general payments reported to CMS, 2019-2025
23 companies · $488 in 2025
The $488 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $1,161 · 2021: $820 · 2022: $823 · 2023: $365 · 2024: $320 · 2025: $488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,172.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,032.72 | 2020-2024 | |
| Stryker Corporation | $846.62 | 2021-2025 | Augment Injectable, Ortholoc 3di, Actishield |
| Integra Lifesciences Corporation | $258.45 | 2021 | |
| Melinta Therapeutics, LLC | $236.50 | 2019-2021 | |
| Depuy Synthes Sales INC. | $202.43 | 2022-2025 | Minibunion, Motoband |
| Orthofix Medical, INC. | $199.47 | 2020-2025 | Physio-Stim |
| Kerecis Limited | $185.26 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $179.84 | 2023 | |
| Nevro Corp. | $160.94 | 2022 | |
| Bone Support INC. | $144.08 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $125.00 | 2020 | |
| Treace Medical Concepts, INC. | $123.13 | 2025 | |
| Ossio INC | $116.75 | 2023 | |
| Smith+Nephew, INC. | $82.59 | 2021-2025 | Grafix Pl, Stravix Pl, Oasis |
| Medtronic, INC. | $78.65 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $34.03 | 2022-2024 | |
| Mimedx Group, INC. | $23.63 | 2024 | |
| Cpm Medical Consultants, LLC | $22.30 | 2019 | |
| Life Spine, INC. | $19.50 | 2020 | |
| Convatec INC. | $19.20 | 2024 | |
| Abbott Laboratories | $14.07 | 2024 | Eterna |
| Nvision Biomedical Technologies, INC. | $13.81 | 2022 | |
| Merck Sharp & Dohme LLC | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roderick Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.